ID

33877

Descripción

Study ID:103860/269 Clinical Study ID:103860/269 (HBV-269) Study Title: Phase II study to evaluate the immunogenicity of GSK Biologicals' preservative-free Engerix-B and thiomersal-free Engerix-B vaccines compared to Engerix™-B and evaluate safety and reactogenicity of each vaccine when administered intramuscularly according to a 0, 1, 6 month schedule in healthy volunteers Patient Level Data:Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: Hepatitis B Vaccine, Recombinant Trade Name: Engerix-B Study Indication: Hepatitis B

Palabras clave

Versiones (1)
  1. 5/1/19 5/1/19 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

5 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Immunogenicity, safety and reactogenicity of preservative-free Engerix-B and thiomersal-free Engerix-B vaccines compared to Engerix™️-B

Inglés

Concomitant Vaccination

1 formularios  
Concomitant Vaccination
Descripción

Concomitant Vaccination

Alias
UMLS CUI-1
C0042196
UMLS CUI-2
C2347852
Has any vaccines other than the study vaccine(s) been administered at ANY time during the study period or within 30 days prior to the first dose of study vaccine(s)?
Descripción

Vaccination, Concomitant Agent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0042196
UMLS CUI [1,2]
C2347852
Trade / Generic Name
Descripción

Vaccines, Name

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0042210
UMLS CUI [1,2]
C0027365
Administration date
Descripción

Vaccination, Concomitant Agent, Date in time

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0042196
UMLS CUI [1,2]
C2347852
UMLS CUI [1,3]
C0011008
Volver a la parte superior de la página

Similar models

Concomitant Vaccination

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Concomitant Vaccination
C0042196 (UMLS CUI-1)
C2347852 (UMLS CUI-2)
Vaccination, Concomitant Agent
Item
Has any vaccines other than the study vaccine(s) been administered at ANY time during the study period or within 30 days prior to the first dose of study vaccine(s)?
boolean
C0042196 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Vaccines, Name
Item
Trade / Generic Name
text
C0042210 (UMLS CUI [1,1])
C0027365 (UMLS CUI [1,2])
Vaccination, Concomitant Agent, Date in time
Item
Administration date
date
C0042196 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial